Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cultured human T-cell lines kill autologous solid tumours

B M Vose, M Moore

    Immunology Letters
    |October 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety gauntlet. Dangerous allergic reactions challenge hospitals' use of latex gloves.

    Modern healthcare·1999
    Same author

    Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CY.

    Bone marrow transplantation·1999
    Same author

    No association between hepatitis C and B-cell lymphoma.

    Hepatology (Baltimore, Md.)·1999
    Same author

    Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.

    Transplantation proceedings·1999
    Same author

    A train passenger with pulmonary tuberculosis: evidence of limited transmission during travel.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1999
    Same author

    Onychomycosis caused by infection with Paecilomyces lilacinus.

    The British journal of dermatology·1999

    Cytotoxic T-cells from cancer patients show significant activity against their own tumors. This suggests a targeted immune response that could be amplified for cancer therapy.

    Area of Science:

    • Immunology
    • Oncology
    • Cell Biology

    Background:

    • Cancer patients often exhibit a suppressed immune response.
    • Identifying and enhancing anti-tumor immune cells is crucial for effective cancer treatment.

    Purpose of the Study:

    • To investigate the cytotoxic activity of lymphocytes from carcinoma patients against autologous tumors.
    • To determine if these lymphocytes recognize tumor-specific antigens.

    Main Methods:

    • Lymphocytes from peripheral blood, lymph nodes, spleen, and tumors of 7 cancer patients were cultured with T-cell growth factor (TCGF; Interleukin 2).
    • Cytotoxic activity was assessed using a 51Cr-release assay against autologous tumor cells, autologous normal cells, and allogeneic tumor targets.

    Main Results:

    Related Experiment Videos

    • Significant cytotoxicity against autologous tumor targets was observed in all patients.
    • This cytotoxicity was specific, as other autologous cells were often resistant.
    • Cytotoxicity generally extended to allogeneic tumor targets, but not to K562 natural killer-sensitive cells.

    Conclusions:

    • The findings support a polyclonal expansion of cytotoxic T-cells in cancer patients.
    • These expanded T-cells recognize antigens expressed on autologous neoplastic cells.
    • This suggests a potential for T-cell based immunotherapies for various carcinomas.